Afilin-M

Product Composition

Each uncoated bilayered tablet contains:

• Montelukast Sodium IP: Equivalent to Montelukast 10 mg.

• Acebrophylline: 200 mg (As sustained release).

• Color: Lake of Quinoline Yellow WS.

Product Summary

Afilin-M is a combination respiratory medication marketed by Healthgate Pvt. Ltd.. It combines a leukotriene receptor antagonist (Montelukast) with a mucolytic and bronchodilator (Acebrophylline) to manage chronic respiratory conditions like asthma and Chronic Obstructive Pulmonary Disease (COPD). The Acebrophylline component is formulated for sustained release to provide prolonged therapeutic effects.

Pros and Cons

Pros

• Dual-Action Therapy: Addresses both airway inflammation (Montelukast) and mucus clearance/bronchial relaxation (Acebrophylline).

• Sustained Release: The 200 mg Acebrophylline dose is released gradually, which may help maintain consistent airway opening.

• Comprehensive Asthma Management: Useful for patients who require more than a single-action bronchodilator to manage their symptoms.

Cons

• Potential Side Effects: May cause gastrointestinal discomfort, dizziness, or headaches in some individuals.

• Strict Administration Requirements: Must be swallowed whole to maintain the sustained-release mechanism.

• Prescription Only: Not suitable for self-medication and requires professional diagnosis.

How to Use

• Administration: The tablet should be swallowed whole; it must not be chewed or crushed as this would destroy the sustained-release property.

• Dosage: As directed by the Physician.

• Storage: Store protected from light and moisture at a temperature not exceeding 30°C.

• Safety: Keep all medicines out of reach of children.

Warning: This is a Schedule H Prescription Drug and should be sold by retail on the prescription of a Registered Medical Practitioner only.